REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 49 filers reported holding REGULUS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,736,000 | -31.6% | 771,485 | +0.3% | 0.00% | – |
| Q3 2016 | $2,539,000 | +16.9% | 769,520 | +2.4% | 0.00% | – |
| Q2 2016 | $2,172,000 | -54.8% | 751,661 | +8.4% | 0.00% | -100.0% |
| Q1 2016 | $4,806,000 | -21.2% | 693,499 | -0.9% | 0.00% | 0.0% |
| Q4 2015 | $6,100,000 | +37.0% | 699,572 | +2.8% | 0.00% | 0.0% |
| Q3 2015 | $4,451,000 | -32.6% | 680,655 | +13.0% | 0.00% | 0.0% |
| Q2 2015 | $6,601,000 | -20.0% | 602,295 | +23.7% | 0.00% | 0.0% |
| Q1 2015 | $8,247,000 | +61.1% | 486,856 | +52.6% | 0.00% | 0.0% |
| Q4 2014 | $5,119,000 | +555.4% | 319,113 | +179.1% | 0.00% | – |
| Q3 2014 | $781,000 | -40.7% | 114,328 | -30.3% | 0.00% | – |
| Q2 2014 | $1,318,000 | +7.0% | 163,958 | +20.1% | 0.00% | – |
| Q1 2014 | $1,232,000 | -31.6% | 136,574 | -44.0% | 0.00% | – |
| Q4 2013 | $1,801,000 | -8.3% | 243,751 | +17.1% | 0.00% | – |
| Q3 2013 | $1,963,000 | +6.8% | 208,126 | +11.1% | 0.00% | – |
| Q2 2013 | $1,838,000 | – | 187,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $943,000 | 0.99% |
| DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
| BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
| Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
| Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
| South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |